SAN DIEGO, CA, Company that provides revolutionary SaaS based data, registration, transaction, and membership management technology, announced today that it has closed its Series B2 financing round. Read More
SAN DIEGO, CA, Privately held biopharmaceutical company has closed the first $25 million tranche of a new $50 million preferred stock financing to support continued advancement of its lead drug candidate, quizartinib. Read More
WALTHAM, MA, Developer of invisible loudspeaker systems, today announced that it has secured $1.05 million in funding from a group of private investors. Read More
